Found 8 matching trials
Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy PHASE3 Primary Objective:
To compare the efficacy of insulin glargine (U300) and ...
Show More Location
Investigational Site Number 1560039
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin PHASE3 Primary Objective:
* To compare the efficacy of insulin glargine new formu...
Show More Location
Investigational Site Number 840156
Learn More & Join Trial
Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM PHASE3 Primary Objective:
To demonstrate the ease of use of the U300 pen injector...
Show More Location
Investigational Site Number 276011
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin PHASE2 Primary Objective:
* To compare the glucose control during treatment with ...
Show More Location
Investigational Site Number 840002
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus PHASE3 Primary Objective:
* To compare the efficacy of a new formulation of insul...
Show More Location
Investigational Site Number 840156
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy PHASE3 Primary Objective:
To compare the efficacy of a new formulation of insulin...
Show More Location
Investigational Site Number 840324
Learn More & Join Trial
Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus PHASE3 Primary Objective:
To compare the efficacy of a new formulation of insulin...
Show More Location
Investigational Site Number 8400008
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy PHASE3 Primary Objective:
* To compare the efficacy of insulin glargine new formu...
Show More Location
Investigational Site Number 840517
Learn More & Join Trial